Medpace is a major clinical contract research organisation (CRO) that provides outsourced clinical development services for drug trials from Phase I to Phase IV. These services are provided to biotechnology, pharmaceutical and medical device customers around the world. 

Running clinical trials is highly complex, and Medpace handles all aspects, including regulatory liaison, site selection and documentation, patient recruitment, and clinical monitoring. 

The company conducts trials across all major therapeutic areas. Oncology is the largest therapeutic area, contributing 32% of revenue, followed by Metabolic (Obesity & Diabetes) and Cardiology.